In a report released today, Ed Arce from H.C. Wainwright maintained Pliant Therapeutics (PLRX – Research Report) to a Buy, with a price target of $52.00. Ed Arce’s Buy rating for Pliant Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results